IFNA1 and diabetes mellitus: In conclusion, the recent research updates in epigenetics, IFN network signaling, and mitochondrial dysfunction in diabetes unveil the possibility of targeting these pathways, particularly in combination with glucose-lowering agents, for comprehensive treatment of diabetic CVD.